Aggressive lymphoma: Low doses of approved drug switches on pathway that allows chemotherapy to kill cancer

Friday, August 16, 2013 - 12:30 in Health & Medicine

Patients with an aggressive lymphoma that often relapses and kills within two years experienced a remission of their cancer and stayed disease-free as long as 28 months after taking a commercially-available drug that made chemotherapy more effective.

Read the whole article on Science Daily

More from Science Daily

Learn more about

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net